APA (7th ed.) Citation

Si Su, Si Su, Liuqing Wu, Guibao Zhou, Lingling Peng, Huanzhe Zhao, . . . Kuan Li. (2023). Indication and adverse event profiles of denosumab and zoledronic acid: Based on U.S. FDA adverse event reporting system (FAERS). Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Si Su, Si Su, Liuqing Wu, Guibao Zhou, Lingling Peng, Huanzhe Zhao, Xiao Wang, Xiao Wang, and Kuan Li. Indication and Adverse Event Profiles of Denosumab and Zoledronic Acid: Based on U.S. FDA Adverse Event Reporting System (FAERS). Frontiers Media S.A., 2023.

MLA (9th ed.) Citation

Si Su, et al. Indication and Adverse Event Profiles of Denosumab and Zoledronic Acid: Based on U.S. FDA Adverse Event Reporting System (FAERS). Frontiers Media S.A., 2023.